Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,580 | 11 | 83.8% |
| Travel and Lodging | $2,383 | 8 | 10.7% |
| Food and Beverage | $1,202 | 25 | 5.4% |
| Education | $15.18 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BTG International, Inc. | $21,745 | 35 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $125.00 | 1 | $0 (2023) |
| ZOLL Medical Corporation | $121.19 | 2 | $0 (2024) |
| Allergan Inc. | $77.70 | 5 | $0 (2019) |
| ZOLL Circulation Inc | $73.34 | 1 | $0 (2023) |
| Teleflex LLC | $20.91 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $16.99 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,306 | 4 | BTG International, Inc. ($3,234) |
| 2023 | $330.71 | 5 | BTG International, Inc. ($132.37) |
| 2022 | $2,068 | 3 | BTG International, Inc. ($2,068) |
| 2021 | $7,189 | 12 | BTG International, Inc. ($7,172) |
| 2020 | $4,390 | 5 | BTG INTERNATIONAL, INC. ($4,341) |
| 2019 | $3,829 | 7 | BTG International, Inc. ($3,793) |
| 2018 | $1,052 | 9 | BTG International, Inc. ($1,005) |
| 2017 | $14.77 | 1 | Allergan Inc. ($14.77) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/11/2024 | BTG International, Inc. | CroFab (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Anti-venom | ||||||
| 05/15/2024 | BTG International, Inc. | CYANOKIT (Drug), CroFab, DIGIFAB | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,040.00 | General |
| Category: Treatment of acute cyanide intoxication | ||||||
| 05/15/2024 | BTG International, Inc. | CYANOKIT (Drug), CroFab, DIGIFAB | Travel and Lodging | Cash or cash equivalent | $178.22 | General |
| Category: Treatment of acute cyanide intoxication | ||||||
| 01/09/2024 | ZOLL Medical Corporation | Defibrillator (Device) | Food and Beverage | Cash or cash equivalent | $71.78 | General |
| Category: Resuscitation | ||||||
| 11/13/2023 | ZOLL Circulation Inc | TherOx DS2 Console (Device), Catheter, Downstream Cartridge | Food and Beverage | Cash or cash equivalent | $73.34 | General |
| Category: TherOx Therapy | ||||||
| 08/01/2023 | BTG International, Inc. | CROFAB (Drug) | Education | In-kind items and services | $7.59 | General |
| Category: Anti-venom | ||||||
| 06/16/2023 | BTG International, Inc. | CROFAB (Drug) | Education | In-kind items and services | $7.59 | General |
| Category: Anti-venom | ||||||
| 06/14/2023 | BTG International, Inc. | DIGIFAB (Drug) | Food and Beverage | In-kind items and services | $117.19 | General |
| Category: Toxicity Antidote (Digoxin Toxicity) | ||||||
| 01/19/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 07/28/2022 | BTG International, Inc. | CROFAB (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,665.00 | General |
| Category: Anti-venom | ||||||
| 07/21/2022 | BTG International, Inc. | CROFAB (Drug) | Food and Beverage | In-kind items and services | $33.01 | General |
| Category: Anti-venom | ||||||
| 02/14/2022 | BTG International, Inc. | CROFAB (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $370.00 | General |
| Category: Anti-venom | ||||||
| 10/28/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/16/2021 | BTG International, Inc. | CROFAB (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,665.00 | General |
| Category: Anti-venom | ||||||
| 07/22/2021 | BTG International, Inc. | CROFAB (Drug) | Travel and Lodging | In-kind items and services | $127.68 | General |
| Category: Anti-venom | ||||||
| 07/22/2021 | BTG International, Inc. | CROFAB (Drug) | Food and Beverage | In-kind items and services | $78.22 | General |
| Category: Anti-venom | ||||||
| 07/19/2021 | BTG International, Inc. | CROFAB (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,665.00 | General |
| Category: Anti-venom | ||||||
| 07/08/2021 | BTG International, Inc. | CROFAB (Drug) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: Anti-venom | ||||||
| 05/20/2021 | BTG International, Inc. | CROFAB (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Anti-venom | ||||||
| 05/20/2021 | BTG International, Inc. | CROFAB (Drug) | Food and Beverage | In-kind items and services | $2.15 | General |
| Category: Anti-venom | ||||||
| 05/13/2021 | BTG International, Inc. | CROFAB (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,960.00 | General |
| Category: Anti-venom | ||||||
| 04/19/2021 | BTG International, Inc. | CROFAB (Drug) | Travel and Lodging | In-kind items and services | $349.93 | General |
| Category: Anti-venom | ||||||
| 04/19/2021 | BTG International, Inc. | CROFAB (Drug) | Travel and Lodging | In-kind items and services | $173.37 | General |
| Category: Anti-venom | ||||||
| 04/19/2021 | BTG International, Inc. | CROFAB (Drug) | Food and Beverage | In-kind items and services | $108.77 | General |
| Category: Anti-venom | ||||||
| 11/27/2020 | BTG INTERNATIONAL, INC. | CROFAB (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,405.00 | General |
| Category: ANTI-VENOM | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 680 | 695 | $1.0M | $77,628 |
| 2021 | 6 | 991 | 1,049 | $1.5M | $120,705 |
| 2020 | 6 | 982 | 1,053 | $1.4M | $105,765 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 314 | 317 | $628,611 | $48,919 | 7.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 75 | 75 | $181,500 | $13,876 | 7.6% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 93 | 94 | $127,500 | $9,976 | 7.8% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 61 | 61 | $54,720 | $3,842 | 7.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 137 | 148 | $13,172 | $1,016 | 7.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 461 | 468 | $928,836 | $78,548 | 8.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 94 | 95 | $229,900 | $19,311 | 8.4% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 107 | 108 | $146,478 | $11,279 | 7.7% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 26 | 53 | $59,606 | $5,372 | 9.0% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 74 | 74 | $66,754 | $4,488 | 6.7% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 229 | 251 | $22,339 | $1,707 | 7.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 400 | 411 | $814,534 | $62,897 | 7.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 88 | 89 | $215,864 | $17,607 | 8.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 103 | 104 | $140,792 | $10,874 | 7.7% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 33 | 75 | $84,748 | $7,606 | 9.0% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 85 | 85 | $76,048 | $4,738 | 6.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 273 | 289 | $27,416 | $2,041 | 7.4% |
About Dr. Benjamin Abo, DO
Dr. Benjamin Abo, DO is a General Acute Care Hospital healthcare provider based in Gainesville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2013. The National Provider Identifier (NPI) number assigned to this provider is 1376885509.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Abo, DO has received a total of $22,180 in payments from pharmaceutical and medical device companies, with $3,306 received in 2024. These payments were reported across 46 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($18,580).
As a Medicare-enrolled provider, Abo has provided services to 2,653 Medicare beneficiaries, totaling 2,797 services with total Medicare billing of $304,099. Data is available for 3 years (2020–2022), covering 17 distinct procedure/service records.
Practice Information
- Specialty General Acute Care Hospital
- Other Specialties Emergency Medicine
- Location Gainesville, FL
- Active Since 03/26/2013
- Last Updated 08/15/2016
- Taxonomy Code 282N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376885509
Products in Payments
- CROFAB (Drug) $18,393
- CYANOKIT (Drug) $3,218
- DIGIFAB (Drug) $117.19
- TherOx DS2 Console (Device) $73.34
- Defibrillator (Device) $71.78
- DALVANCE (Drug) $50.21
- TEFLARO (Drug) $27.49
- AIRWAY MANAGEMENT - LMA, RUSCH & TELEFLEX BRANDS (Device) $20.91
- XARELTO (Drug) $16.99
- CroFab (Drug) $16.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Acute Care Hospital Doctors in Gainesville
Dr. Rene Przkora, M.d., Ph.d., Mms, M.D., PH.D., MMS
General Acute Care Hospital — Payments: $1,944
Suman Thapa, M.d, M.D
General Acute Care Hospital — Payments: $285.52
Dr. Sarinya Puwanant, Md, MD
General Acute Care Hospital
Ms. Maja Kubicka, M.d, M.D
General Acute Care Hospital
Michele Bone, Rn, RN
General Acute Care Hospital
Dr. Harold Hunt, Md, MD
General Acute Care Hospital